drugset / Trial / NCT06699810

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

NCT06699810

Phase 4 Recruiting 12 enrolled Emory University
NaSingle-groupOpen-labelBasic science

Summary

The goal of this study is to quantify day-to-day changes in blood glucose during treatment towards remission in ketosis-prone diabetes (KPDM) and describe them using a mathematical model of KPDM pathogenesis and remission.

Timeline

Start
2025-01-23
Primary completion
2027-01
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic

Indications